Sexual Health & Medical Wellness Artificial Intelligence Uncovers Potential Underreported Side Effects of GLP-1 Medications Through Social Media Analysis September 21, 2026 Susilo Ahmad The rapid ascent of GLP-1 receptor agonists—a class of drugs including semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound)—has transformed the landscape of obesity and diabetes…
